not truly a sedative agent, ketamine has emerged as another potential agent for facilitating RSI. Ketamine is a dissociative agent. In the absence of neuromuscular blockade use, ketamine maintains airway reflexes. Ketamine is also not associated with significant hypotension. Side effects of ketamine include increased secretions and potential increase of intracranial pressure. While the latter could be harmful in patients with traumatic brain injury, the association of ketamine use with outcomes in these patients is unclear. Ketamine is typically dosed at 1 to 2 mg/kg intravenously, or 2 to 4 mg/kg if given intramuscularly.
Paralysis
The most commonly used neuromuscular blocking agent for RSI is succinylcholine, typically administered at a dose of 1.0–2.0 mg/kg intravenously (70–140 mg in a typical 70‐kg patient). Succinylcholine’s rapid onset and short duration of action are ideal for RSI. The rationale for using a rapid‐acting paralytic is to achieve intubating conditions as quickly as possible. The rationale for using a short‐acting paralytic is to facilitate rapid recovery of the patient’s spontaneous airway reflexes in the event of unsuccessful laryngoscopy and intubation efforts.
Relative contraindications to succinylcholine include conditions with known hyperkalemia, such as acute renal failure or rhabdomyolysis. Succinylcholine‐induced hyperkalemia in these settings may cause cardiopulmonary arrest. While burn injuries can cause hyperkalemia, this complication usually does not occur until 2 or 3 days after the acute injury. Succinylcholine can be safely used for the acute management of burn victims. Other relative contraindications to succinylcholine include muscular‐wasting diseases (which can cause hyperkalemia) and pseudocholinesterase deficiency that prolongs the neuromuscular blockade due to slower drug metabolism.
Nondepolarizing agents such as rocuronium and vecuronium may be used as alternatives to succinylcholine for RSI. Rocuronium, dosed at 1 mg/kg, has a rapid onset (1–3 minutes), although its duration of action (30–45 minutes) is longer than succinylcholine (5–9 minutes). Vecuronium, dosed at 0.1 mg/kg, has a slightly longer onset of action (2–4 minutes), and duration of 25–40 minutes. “High‐dose” vecuronium (0.15–0.28 mg/kg) has an even longer duration of action (60–120 minutes). Clinicians should anticipate prolonged recovery time from vecuronium in obese patients, elderly patients, and those with hepatorenal dysfunction. Both rocuronium and vecuronium can be reversed by sugammadex (2–4 mg/kg).
After successful RSI, it is essential to administer additional medications to maintain sedation and paralysis. Therefore, EMS clinicians performing RSI should carry longer‐acting paralytics (for example, vecuronium) and longer‐acting sedative agents (for example, lorazepam, midazolam, or diazepam).
Pediatric practices for RSI often vary slightly from adult protocols. The pediatric literature raises concern regarding the possibility of unrecognized muscular myopathies, which would result in hyperkalemia with administration of succinylcholine [78]. Therefore, many specialty pediatric transport teams use nondepolarizing agents to facilitate paralysis. The use of etomidate for children remains unresolved. Prehospital RSI protocols vary between the use of etomidate and midazolam for sedation. Because of paradoxical bradycardia with RSI agents in children, clinicians may pretreat patients with intravenous atropine.
Sedation‐assisted endotracheal intubation
Sedation‐assisted intubation is intubation using a sedative agent only, without concurrent neuromuscular blocking agents [7579–83]. Medications used to facilitate intubation in this manner include benzodiazepines (midazolam or diazepam), etomidate, and ketamine. Sedation‐assisted intubation historically resulted from the belief that intubation is safer without than with the use of neuromuscular blockade. However, critics of the technique note that incomplete ablation of the gag reflex can potentiate the threat of vomiting and aspiration. Also, first‐pass intubation success is optimized with the use of neuromuscular blockade. Consequently, most EMS medical directors strongly discourage the use of sedation‐assisted intubation.
Other drug‐facilitated techniques
Safe RSI requires meticulous preparation and preoxygenation to avoid peri‐intubation adverse events. Adequate preoxygenation for RSI may require application of 100% oxygen for at least 3 minutes. However, proper preparation for RSI may not be possible with a combative or agitated patient. Delayed sequence intubation involves the initial delivery of a sedative to facilitate patient positioning, preparation, and preoxygenation, and subsequent delayed administration of paralytic and intubation [84]. The time interval between sedative and paralytic may be 5‐10 minutes or even longer. Delayed sequence intubation may be accomplished using any induction agent. EMS experience with this technique is limited [85].
Conclusion
Airway management is one of the most important elements of prehospital emergency care. Prehospital airway management involves numerous clinical, educational, and system‐level complexities. EMS physicians and medical directors must be familiar with the myriad of issues related to prehospital airway care.
References
1 1 Brown CA, 3rd, Mosier JM, Carlson JN, Gibbs MA. Pragmatic recommendations for intubating critically ill patients with suspected COVID‐19. J Am Coll Emerg Physicians Open. April 13, 2020. doi: 10.1002/emp2.12063.
2 2 Davidovic L, LaCovey D, Pitetti RD. Comparison of 1‐ versus 2‐person bag‐valve‐mask techniques for manikin ventilation of infants and children. Ann Emerg Med. 2005; 46:37–42.
3 3 Otten D, Liao MM, Wolken R, et al. Comparison of bag‐valve‐mask hand‐sealing techniques in a simulated model. Ann Emerg Med. 2014; 63:6–12.
4 4 Kurola J, Harve H, Kettunen T, et al. Airway management in cardiac arrest–comparison of the laryngeal tube, tracheal intubation and bag‐valve mask ventilation in emergency medical training. Resuscitation. 2004; 61:149–53.
5 5 Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure in preventing gastric inflation during bag‐mask ventilation in pediatric patients. Anesthesiology. 1974; 40:96–98.
6 6 Moynihan RJ, Brock‐Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of cricoid pressure on preventing gastric insufflation in infants and children. Anesthesiology. 1993; 78:652–56.
7 7 Petito SP, Russell WJ. The prevention of gastric inflation–a neglected benefit of cricoid pressure. Anaesth Intensive Care. 1988; 16:139–43.
8 8 Fanning GL. The efficacy of cricoid pressure in preventing regurgitation of gastric contents. Anesthesiology. 1970; 32:553–5.
9 9 Birenbaum A, Hajage D, Roche S, et al. Effect of cricoid pressure compared with a sham procedure in the rapid sequence induction of anesthesia: the IRIS randomized clinical trial. JAMA Surgery. 2019; 154:9–17.
10 10 Updike G, Mosesso VN, Jr., Auble TE, Delgado E. Comparison of bag‐valve‐mask, manually triggered ventilator, and automated ventilator devices used while ventilating a nonintubated mannikin model. Prehosp Emerg Care. 1998; 2:52–55.
11 11 Menegazzi JJ, Winslow HJ. In‐vitro comparison of bag‐valve‐mask and the manually triggered oxygen‐powered breathing device. Acad Emerg Med. 1994; 1:29–33.
12 12 Caples SM, Gay PC. Noninvasive positive pressure ventilation in the intensive care unit: a concise review. Crit Care Med. 2005; 33:2651–8.
13 13 Hubble MW, Richards ME, Jarvis R, Millikan T, Young D. Effectiveness of prehospital continuous positive airway pressure in the management of acute pulmonary edema.
